Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A MULTICENTER OPEN-LABEL STUDY OF ETANERCEPT WITHDRAWAL AND RETREATMENT IN SUBJECTS WITH NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS WHO ACHIEVED ADEQUATE 24 WEEK RESPONSE

NCT02509026 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT02509026
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02509026 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A MULTICENTER OPEN-LABEL STUDY OF ETANERCEPT WITHDRAWAL AND RETREATMENT IN SUBJECTS WITH NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS WHO ACHIEVED ADEQUATE 24 WEEK RESPONSE
Lead sponsor
Pfizer
Phase
Phase 4
Overall status
Completed
Start date
September 24, 2015
Completion date
September 6, 2019
Enrollment
210 (actual)
Sites
82

Conditions

As the registry lists them; a condition with its own page is linked.

spondylitis, ankylosing